Case series of patients treated with the oral fluoropyrimidine S-1 after capecitabine-induced coronary artery vasospasm

Eur J Cancer. 2017 Aug:81:130-134. doi: 10.1016/j.ejca.2017.05.022. Epub 2017 Jun 15.
No abstract available

Publication types

  • Letter

MeSH terms

  • Administration, Oral
  • Aged
  • Breast Neoplasms / drug therapy
  • Breast Neoplasms / epidemiology
  • Breast Neoplasms / pathology
  • Capecitabine / adverse effects*
  • Cardiotoxicity / epidemiology
  • Colorectal Neoplasms / drug therapy
  • Colorectal Neoplasms / epidemiology
  • Colorectal Neoplasms / pathology
  • Coronary Vasospasm / chemically induced*
  • Coronary Vasospasm / epidemiology
  • Drug Combinations
  • Drug Substitution*
  • Female
  • Humans
  • Male
  • Middle Aged
  • Oxonic Acid / administration & dosage*
  • Stomach Neoplasms / drug therapy
  • Stomach Neoplasms / epidemiology
  • Stomach Neoplasms / pathology
  • Tegafur / administration & dosage*

Substances

  • Drug Combinations
  • S 1 (combination)
  • Tegafur
  • Oxonic Acid
  • Capecitabine